Table 1.
Study Design |
Duration | n (Study Group/ Control Group) |
Age, Years | BMI | Dose | Control Group | Tested Parameters | |
---|---|---|---|---|---|---|---|---|
Rahmani, 2016 [23] |
RCT | 8 weeks | 37/40 | 46.3 11.57 | 30.84 | 500 mg/day of an amorphous dispersion preparation comprising 70 mg curcuminoids | Received placebo | ALT, AST, BMI, FGB, HbA1c, HDL-C, LDL-C, TC, TG, body weight |
Kelardeh, 2017 [24] | RCT | 12 weeks | 12/12 | 37.41 5.17 | 29.88 | 80 mg/day curcumin as a nanomicelle | Received one placebo (3 g dextrose) capsule per day | ALT, AST, ALP, BMI, WC |
Navekar, 2017 [25] |
DB, RCT | 12 weeks | 21/21 | 31.81 | 3 g/day turmeric (6 × 500 mg three times a day) | Patients were given six placebo capsules daily | ALT, AST, BMI, FGB, FBI, HOMA-IR, body weight | |
Chashmniam, 2019 [26] | DB, RCT | 8 weeks | 25/20 | 46.56 2.25 | 30.03 | Phospholipid curcumin 250 mg/day (equivalent to 50 mg pure curcumin) | Received one placebo capsule per day | ALT, AST, ALP, BMI, D Bili, FGB, HDL-C, LDL-C, TC, TG, T Bili, body weight |
Mirhafez, 2019 [27] | DB, RCT | 8 weeks | 32/29 | 44.8 | 30.06 | Phospholipid curcumin 250 mg/day (equivalent to 50 mg pure curcumin) | Received a placebo | ALT, AST, BMI, FGB, HDL-C, LDL-C, TC, TG, body weight |
Hariri, 2020 [28] |
DB, RCT | 8 weeks | 23/22 | 40.95 | 30.59 | Phospholipid curcumin 250 mg/day (equivalent to 50 mg pure curcumin) | Received a placebo | ALT, AST, BMI, WC, body weight |
Kelardeh, 2020 [29] | RCT | 12 weeks | 11/11 | 66.72 | 27.60 | 80 mg/day curcumin as a nanomicelle | Received a placebo capsule | ALP, BMI, T Bili, body weight |
Saberi-Karimian, 2020 [30] | RCT | 8 weeks | 23/26 | 18–70 | 30.02 | 500 mg curcuminoids + 5 mg piperine/day | Received one placebo capsule per day | ALT, AST, TG, TC, LDL-C, HDL-C, BDP, SBP, FBG, WC, BMI, body weight |
ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; Creat, creatinine; CT, clinical trial; DB, double blind; DBP, diastolic blood pressure; D Bili, direct bilirubin; FGB, fasting blood glucose; FBI, fasting blood insulin; HbA1c, glycated hemoglobin; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; LDL-C, low-density lipoprotein cholesterol; RCT, randomized controlled trial; SBP, systolic blood pressure; TC, total cholesterol; TG, total triglycerides; T Bili, total bilirubin; WC, waist circumference.